Please note that medications should be stored out of the reach of children
NOTIFICATION REGARDING THE BOTTLED PACKAGES OF ATTENT 10MG, 20MG, 30MG
Teva Pharmaceutical Industries Ltd., the marketer of Attent, wishes to draw the public's attention to the fact that the current bottled packaging of the below listed batches, is similar to the packaging available in the US market, and does not include a child resistant cap. Please note there is absolutely no defect or quality issue with the product, and the Ministry of Health's recommendation is to continue using it in accordance with the instructions given by the treating physician.
Teva is acting to ensure the availability of the product - including a protective mechanism to prevent opening of the cap by a child - as soon as possible, and until such will be available in the market, a warning label will be added to the existing cap, according to the following illustration.
Teva wishes to remind the public that medications should be stored out of reach of children and in accordance with the instructions detailed in the Patient Information Leaflet.

Current illustration | Illustration with the warning label |
![]() |
![]() |